Learn more about the companies developing precision medicines that target rare diseases. General Partner Marco Boorsma PhD speaks about building, enabling, transforming and growing businesses using the most innovative science. BGV Venture Partner and COO VectorY Elena Ritsou, PhD discusses her work with the team.